Skip to content
Alivio del Dolor

Tramadol Drops

Información sobre Tramadol Drops (oral solution) for moderate to severe pain. Posología, efectos secundarios, EU doctor review via Prescrivia.

2026-04-12 Tramadol Oral Solution

From €75.00

Incluye tarifa de plataforma, revisión médica y tarifas de dispensación según la ruta.

Continuar con la ruta de receta en papel

Concentraciones y tipos

Recibir notificación cuando esté en stock

Las farmacias asociadas no disponen actualmente de esta concentración/tipo. El inicio de la evaluación para la dispensación por farmacia asociada está en pausa para esta opción.

Continuar con la ruta de receta en papel

La ruta de receta en papel significa que un médico independiente puede emitir una receta para que usted la presente en una farmacia local. La aceptación queda sujeta a las políticas internas de cada farmacia.

What are Tramadol Drops?

Tramadol Drops is an oral solution formulation of tramadol hydrochloride — the same active ingredient found in tramadol tablets and capsules. Available as a liquid taken by mouth, Tramadol Drops are indicated for the management of moderate to moderately severe pain in adults and are a prescription-only controlled medicine in most EU member states. The oral solution formulation is particularly suited to patients who have difficulty swallowing tablets or who require flexible dose adjustment.

How do Tramadol Drops work?

Tramadol Drops work through the same dual analgesic mechanism as other tramadol formulations:

  • Opioid receptor agonism: Tramadol and its active metabolite O-desmethyltramadol (M1) bind to mu-opioid receptors in the central nervous system, reducing the transmission and perception of pain signals along ascending nociceptive pathways.
  • Monoamine reuptake inhibition: Tramadol inhibits the reuptake of serotonin and noradrenaline in central synapses. This component modulates the descending pain-inhibitory system and contributes to tramadol’s efficacy in neuropathic and mixed-mechanism pain states.
  • Pharmacokinetics of the oral solution: Following oral administration, tramadol solution is absorbed from the gastrointestinal tract. Peak plasma concentrations are typically reached within one to two hours. Because the oral solution does not require tablet disintegration, absorption may begin slightly earlier than with solid dosage forms in some individuals, though overall bioavailability is comparable.
  • Metabolic pathway: Tramadol is metabolised primarily via CYP2D6 and CYP3A4 enzymes. Genetic variation in CYP2D6 affects the extent of M1 metabolite formation, which in turn influences the opioid component of analgesia.

Who are Tramadol Drops for?

Tramadol Drops are indicated for adults (18 years and over) with moderate to moderately severe pain who require tramadol therapy and for whom the oral solution formulation is clinically indicated. The oral solution may be particularly appropriate for:

  • Patients with dysphagia: Difficulty swallowing tablets or capsules due to neurological conditions, anatomical abnormalities, age-related swallowing difficulties, or post-surgical changes
  • Elderly patients: Where lower initial doses and flexible titration are clinically important
  • Patients requiring flexible dosing: Clinical situations where precise, granular dose adjustments are needed to balance efficacy and tolerability
  • Patients with nasogastric or gastric feeding tubes: Where the liquid form is more practical (subject to compatibility assessment by a clinical pharmacist)
  • Acute pain management: When dose flexibility is particularly important during initial titration

Tramadol Drops are not appropriate for children under 18, patients with epilepsy or a lowered seizure threshold, those taking MAO inhibitors, patients in acute opioid withdrawal, or those with significant respiratory depression. Se requiere una evaluación médica completa antes de emitir cualquier receta.

Posología

Tramadol oral solution concentrations vary by product. A commonly available concentration is 100 mg/ml (providing 2.5 mg per drop), but patients must always verify the concentration of their specific product and use the measuring device provided.

Patient GroupTypical Starting DoseDosing IntervalMaximum Daily Dose
Adults (18–74 years)50–100 mg (20–40 drops at 2.5 mg/drop)Every 4–6 hours400 mg/day
Elderly (75+ years)50 mg (20 drops)Every 6 hours300 mg/day (guidance varies)
Renal impairment (mild–moderate)50 mgEvery 12 hoursAdjusted per clinical guidance
Hepatic impairment (mild–moderate)50 mgIncreased intervalsAdjusted per clinical guidance

The oral solution should be measured carefully using the provided dropper or syringe, mixed into a small amount of water or juice if preferred, and swallowed. It must not be injected. Doses should not be estimated without the measuring device.

Tramadol Drops should be used at the lowest effective dose for the shortest duration necessary to control pain. Doses should not be adjusted without guidance from the prescribing doctor.

Efectos secundarios

The side effect profile of Tramadol Drops is the same as for other tramadol formulations, since the active ingredient is identical. All opioid-related and serotonin-related risks apply equally.

Efectos secundarios frecuentes (pueden afectar a más de 1 de cada 10 personas)

  • Nausea and vomiting (particularly on initiation)
  • Dizziness and vertigo
  • Drowsiness and sedation
  • Headache
  • Constipation
  • Dry mouth
  • Sweating

Efectos secundarios poco frecuentes pero graves

  • Seizures: Tramadol lowers the seizure threshold. The risk is increased at higher doses, in patients with epilepsy, and when combined with medications that also lower the seizure threshold (antidepressants, antipsychotics, bupropion).
  • Serotonin syndrome: Combining tramadol with SSRIs, SNRIs, MAO inhibitors, triptans, or linezolid creates a risk of serotonin syndrome — a potentially life-threatening condition requiring immediate medical attention.
  • Dependence and withdrawal: Regular use of tramadol can lead to physical and psychological dependence. Abrupt discontinuation should be avoided; dose tapering under medical supervision is recommended.
  • Respiratory depression: Particularly at high doses or in combination with other CNS depressants, tramadol can suppress respiratory drive.
  • Dosing errors with oral solution: The liquid formulation carries a specific risk of measurement errors. Always use the provided calibrated measuring device and verify the concentration of the product before administering.

Esta no es una lista completa de efectos secundarios. Consulte la información del producto aprobada por la EMA para obtener los detalles completos de prescripción.

How to get Tramadol Drops online in Europe

Tramadol hydrochloride, including in oral solution form, is a prescription-only controlled medicine in most EU member states. No puede dispensarse legalmente sin una receta válida de un profesional médico autorizado.

Prescrivia opera como plataforma intermediaria tecnológica: no prescribimos medicamentos, no empleamos médicos ni vendemos medicamentos. Nuestra plataforma conecta a los pacientes con médicos independientes registrados en la UE que pueden realizar evaluaciones de salud en línea confidenciales.

El proceso funciona de la siguiente manera:

  1. Complete una evaluación de salud: Responda a un conjunto estructurado de preguntas de salud covering your medical history, current medications, pain history, any prior use of opioid medicines, and the clinical reason you may require an oral solution formulation.
  2. Revisión médica: Un médico independiente registrado en la UE revisa su evaluación. If Tramadol Drops are clinically appropriate for your situation, they may issue a prescription. If an alternative formulation or medicine is more suitable, the doctor will advise accordingly.
  3. Prescripción y dispensación: Si se emite una receta, se remite a una farmacia asociada autorizada de la UE, que dispensa y envía el medicamento directamente a usted.

Importante: Prescrivia no garantiza que se emita una receta. Todas las decisiones de prescripción son tomadas de forma independiente por profesionales médicos cualificados en función de sus circunstancias clínicas individuales.

Información importante de seguridad

No utilice Tramadol Drops si usted:

  • Are under 18 years of age
  • Have epilepsy or a history of seizures
  • Are taking or have recently taken MAO inhibitors (within 14 days)
  • Are in acute opioid withdrawal
  • Have acute alcohol intoxication or are under the influence of hypnotics, opioid analgesics, or psychotropic medicines
  • Have significant respiratory depression or severe asthma

Informe a su médico antes de starting Tramadol Drops if you have:

  • A personal or family history of epilepsy or seizures
  • A history of opioid dependence or substance misuse
  • Liver or kidney disease
  • Head injury or raised intracranial pressure
  • Depression, anxiety, or are taking antidepressant medication
  • Swallowing difficulties or a feeding tube (confirm compatibility)
  • Adrenal insufficiency or hypothyroidism

Measuring safely: Always use the calibrated dropper or dosing syringe provided with the product. Check the product label for the exact concentration (mg/ml or mg/drop) before each use. Never use household spoons for measuring. Store out of reach of children.

Interacciones medicamentosas: Tramadol Drops carry the same drug interaction risks as tramadol tablets, including interactions with SSRIs, SNRIs, MAO inhibitors, triptans, anticoagulants, CYP2D6/CYP3A4 inhibitors and inducers, antiepileptics, and CNS depressants including alcohol and benzodiazepines. Informe siempre a su médico de todos los medicamentos que toma actualmente.

Fuentes

La información médica de esta página se basa en las siguientes fuentes:

  • European Medicines Agency (EMA). Tramadol hydrochloride — Summary of Product Characteristics. Disponible en: ema.europa.eu
  • World Health Organization (WHO). WHO Model List of Essential Medicines — Medicines for pain and palliative care. who.int
  • Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879-923.
  • European Medicines Agency (EMA). Assessment reports for tramadol oral formulations. Disponible en: ema.europa.eu

Este contenido se revisa periódicamente para reflejar las directrices clínicas actualizadas. Se proporciona únicamente con fines informativos y no constituye asesoramiento médico. Consulte siempre a un profesional sanitario cualificado para obtener asesoramiento relevante para sus circunstancias de salud individuales.

Frequently asked questions

What are Tramadol Drops?
Tramadol Drops is an oral solution formulation of tramadol hydrochloride. It contains the same active ingredient as tramadol tablets or capsules but is administered in liquid form, making it useful for patients who have difficulty swallowing solid oral dosage forms, or when precise dose titration is required.
Are Tramadol Drops the same as Tramadol tablets?
Tramadol Drops contain the same active ingredient — tramadol hydrochloride — as tramadol tablets and capsules, and work via the same mechanism. The primary difference is the route of administration (liquid vs solid). The oral solution may have a slightly faster onset due to more rapid gastric absorption in some patients.
Can I get Tramadol Drops online in Europe?
Tramadol is a prescription-only controlled medicine in most EU member states regardless of formulation, including the oral solution. Prescrivia connects patients with independent EU-registered doctors who can assess whether Tramadol Drops are clinically appropriate for their situation.
How do I measure the correct dose of Tramadol Drops?
Tramadol oral solution comes with a calibrated measuring device (dropper or dosing syringe). Each drop contains a fixed amount of tramadol (typically 2.5 mg per drop, but this varies by product — always check the prescribing information). Never estimate the dose without measuring; using the provided device is essential for accurate dosing.
Who might benefit from Tramadol Drops over tablets?
Tramadol Drops may be preferred for patients with swallowing difficulties (dysphagia), elderly patients requiring lower or more precisely titrated doses, patients with nasogastric feeding tubes (where appropriate), or patients in acute situations where rapid dose adjustment is clinically necessary.

Prescrivia es únicamente una plataforma intermediaria. No prestamos servicios médicos, no prescribimos tratamientos ni dispensamos medicamentos. Todas las decisiones médicas son tomadas por médicos independientes registrados en la UE. Todos los medicamentos son dispensados por farmacias autorizadas de la UE. Esta plataforma facilita la conexión entre pacientes y profesionales sanitarios.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

¿Listo para empezar?

Complete una evaluación de salud confidencial en unos 3 minutos.